Log in to save to my catalogue

P41 Biochemical response to bezafibrate amongst patients with PBC and ursodeoxycholic acid non-respo...

P41 Biochemical response to bezafibrate amongst patients with PBC and ursodeoxycholic acid non-respo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2866435277

P41 Biochemical response to bezafibrate amongst patients with PBC and ursodeoxycholic acid non-response

About this item

Full title

P41 Biochemical response to bezafibrate amongst patients with PBC and ursodeoxycholic acid non-response

Publisher

London: BMJ Publishing Group LTD

Journal title

Gut, 2023-09, Vol.72 (Suppl 3), p.A39-A39

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundA 14-centre study of second line therapies for PBC in England identified no difference in biochemical response rates between patients treated with Obeticholic acid (OCA) vs fibrates. However, patients treated with OCA had higher rates of ALT and bilirubin normalisation, with rates of normalisation not significant amongst fibrate treated p...

Alternative Titles

Full title

P41 Biochemical response to bezafibrate amongst patients with PBC and ursodeoxycholic acid non-response

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2866435277

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2866435277

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2023-BASL.57

How to access this item